These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26335644)

  • 1. Loss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.
    Borgkvist A; Avegno EM; Wong MY; Kheirbek MA; Sonders MS; Hen R; Sulzer D
    Neuron; 2015 Sep; 87(5):976-88. PubMed ID: 26335644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.
    Taverna S; Ilijic E; Surmeier DJ
    J Neurosci; 2008 May; 28(21):5504-12. PubMed ID: 18495884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
    Rubi L; Fritschy JM
    J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.
    Ding S; Li L; Zhou FM
    J Neurophysiol; 2015 May; 113(9):3397-409. PubMed ID: 25787955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA: Inhibition brings new excitement in Parkinson's disease.
    Castela I
    Mov Disord; 2016 Mar; 31(3):297. PubMed ID: 26861776
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neostriatal GABAergic Interneurons Mediate Cholinergic Inhibition of Spiny Projection Neurons.
    Faust TW; Assous M; Tepper JM; Koós T
    J Neurosci; 2016 Sep; 36(36):9505-11. PubMed ID: 27605623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
    Mango D; Bonito-Oliva A; Ledonne A; Cappellacci L; Petrelli R; Nisticò R; Berretta N; Fisone G; Mercuri NB
    Exp Neurol; 2014 Nov; 261():733-43. PubMed ID: 25173217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice.
    Parker PR; Lalive AL; Kreitzer AC
    Neuron; 2016 Feb; 89(4):734-40. PubMed ID: 26833136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice.
    Wei W; Li L; Yu G; Ding S; Li C; Zhou FM
    J Neurophysiol; 2013 Nov; 110(9):2203-16. PubMed ID: 23945778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism.
    Mabrouk OS; Volta M; Marti M; Morari M
    J Neurochem; 2008 Dec; 107(6):1647-59. PubMed ID: 19094058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
    Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.
    Bergstrom BP; Sanberg SG; Andersson M; Mithyantha J; Carroll FI; Garris PA
    Neuroscience; 2011 Oct; 193():310-22. PubMed ID: 21787843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
    Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
    Zhang K; Chammas C; Soghomonian JJ
    Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
    Fantin M; Auberson YP; Morari M
    J Neurochem; 2008 Jul; 106(2):957-68. PubMed ID: 18435828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.